Chemicals and pharmaceuticals · ARWR

ARROWHEAD PHARMACEUTICALS, INC.

12 filings mentioning 8 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
8topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

Across 12 filings we hold, ARROWHEAD PHARMACEUTICALS, INC. has written down 8 of the topics we track. That places it 15 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

ARWR Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something ARROWHEAD PHARMACEUTICALS, INC. has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO 27001:202242
ISO 37001:201639
ASD Strategies to Mitigate Cyber Security Incidents29
GDPR26
ISO 3700126
Code of Conduct on Data Protection for Research (GDPR Article 40)12
COSO Internal Control9
Basel III International Banking Framework6
NIST SP 800-615

10 frameworks, 272 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Ransomware7
Internal Control4
Records Retention2
Regulatory Reporting2
Material Weakness1
Restatement1
Consent Order1
Regulatory Investigation1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Ransomware72025-11-25
Internal Control42026-01-09
Records Retention22024-02-06
Regulatory Reporting22024-02-06
Material Weakness12019-12-06
Restatement12022-12-08
Consent Order12026-01-12
Regulatory Investigation12026-01-12

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-01-128-KEntry into a material agreement, Item 2.03, Financial statements and exhibitsfiling
2026-01-098-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2025-11-2510-Kfiling
2024-11-2610-Kfiling
2024-02-0610-Qfiling
2024-01-048-KEntry into a material agreement, Financial statements and exhibitsfiling
2023-11-2910-Kfiling
2022-12-088-KEntry into a material agreement, Financial statements and exhibitsfiling
2022-11-2810-Kfiling
2021-11-2210-Kfiling
2020-11-2310-Kfiling
2019-12-068-KEntry into a material agreement, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition